Two start-ups have launched to develop next-generation drugs using small interfering RNA (siRNA) to silence genes. The first, Judo Bio, is a spin-off of the venture capital firm Atlas Venture.
News Medical on MSN1mon
Scientists pinpoint thousands of gene variants linked to breast and ovarian cancer riskThe RAD51C gene encodes a protein crucial for DNA repair. Variants in this gene that stop the protein from working are known ...
Reporting in Nature, Kumar and colleagues have now developed a method to target small-interfering RNA (siRNA) to the CNS, providing a safe and non-invasive approach for the delivery of this new ...
1monon MSN
Researchers from the Wellcome Sanger Institute and their collaborators have made significant strides in understanding the ...
About GalNAc Ternary architectures of N-Acetylgalactosamine are used as targeting and internalizing ligands for investigational (and approved) oligonucleotide-based antisense and siRNA ...
Ibsa waa'ee suuraa, Manguddoota Booranaa yeroo sirna Gadaa. 18 Amajjii 2021 Hariiroo waliin jireenya namootaa keessatti namni tokko itti yaadees haa ta'u tasa lubbuu nama kan biraa balleessuu dandaha.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback